Praxis Precision Medicines Provides Corporate Update and
Cash and investments of $165.4 million as of June 30, 2022 supports runway into 1Q24. BOSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage ...